Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats

<table>Representative M-mode images showing cardiac function and left ventricle chamber dimensions in sham, MI, and MI + HP<i>β</i>CD/Ang-(1–7)-treated rats. Note the marked increase in end-systolic dimension (ESD) and in end-diastolic dimension (EDD) after infarction and the improvement in the cardiac function after 50 days in rats treated with HP<i>β</i>CD/Ang-(1–7).</table>

International Journal of Hypertension

fig2

Figure 2

Figure 2: Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats 